In this episode, Dr. Amir Reuveny, Founder and CEO of Wesper, joins Omar Khateeb to unpack why sleep diagnostics are becoming increasingly important as the treatment landscape for sleep apnea expands.Amir shares how watching his father struggle with unrecognized sleep apnea eventually connected with his academic work in flexible electronics, leading him to build technology designed around comfortable, clinical-grade home testing. Wesper’s platform uses flexible body sensors and pulse oximetry while generating respiratory data physicians traditionally relied on sleep laboratories to collect.

The discussion explores the rise of GLP-1 therapies, CPAP alternatives, oral appliances, surgical treatments, and why a broader range of therapies is increasing the need for accessible diagnosis and ongoing monitoring.Amir and Omar also examine how sleep care is moving beyond specialized sleep medicine into obesity medicine, primary care, ENT, dentistry, and home-based diagnostics, creating a much larger ecosystem around sleep apnea care.

The episode offers a compelling look at how materials science, medical devices, software, and changing treatment pathways could move sleep medicine from isolated testing toward more continuous and personalized care. 

DISCLAIMER

This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions.

Episode Breakdown:

00:00 Why 80% of Sleep Apnea Cases Go Undiagnosed

01:38 Intro + Meet Amir Reuveny

02:47 From Flexible Electronics to MedTech Founder

03:44 The Personal Story Behind Wesper

05:15 Making Sleep Apnea Testing Easier at Home

06:20 How Flexible Electronics Changed Sleep Testing

09:11 GLP-1s Are Changing Sleep Apnea Treatment

12:08 CPAP, GLP-1s and New Treatment Options

13:38 How Wesper Improves At-Home Sleep Testing

16:09 Inside the Wesper Sleep Testing System

18:14 How Wesper Compares to Traditional Sleep Tests

20:02 Commercializing At-Home Sleep Diagnostics

20:52 How Wesper Reaches Physicians and Health Systems

22:45 Why Sleep Care Is Moving Upstream

23:51 The New Wesper Sleep Ecosystem

25:45 From One-Night Testing to Continuous Monitoring

26:55 Expanding Into Obesity, ENT and Primary Care

28:27 ResMed and the Future of Sleep Tech

29:47 Could Pharma Acquire a Sleep Tech Company?

31:09 New Investors Entering the Sleep Market

31:54 What’s Next for Wesper

32:28 Final Thoughts

32:38 Outro

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBEYouTube: https://www.youtube.com/@thestateofmedtechLinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECHLinkedIn: https://www.linkedin.com/company/thestateofmedtech/Instagram: https://www.instagram.com/stateofmedtech/TikTok: https://www.tiktok.com/@stateofmedtechpodX: https://x.com/stateofmedtechFacebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEBLinkedIn: https://www.linkedin.com/in/okhateeb/Instagram: https://www.instagram.com/omar.m.khateeb/TikTok: https://www.tiktok.com/@omar.m.khateebX: https://x.com/OmarMKhateebFacebook: https://www.facebook.com/OmarMKhateeb

Watch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNf

Join Omar at Medtech CEO Camp in Boston https://www.campcuriae.com/

#sleepapnea #sleeptechnology #medtech #digitalhealth #healthcareinnovation

Watch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNfJoin Omar at Medtech CEO Camp in Boston. Use code MC1000 for $1,000 off. https://www.campcuriae.com/

In this solo episode, Omar Khateeb explains why most MedTech investor decks fail to create conviction and how founders can build presentations that make the market opportunity, adoption path, and use of capital clear.

A strong pitch deck is more than a sequence of product, market, competition, team, and financial slides. It is an exercise in market engineering and persuasion. Investors need to see not only that the technology works, but also how the market will understand, adopt, and scale around it.

Omar breaks down category design, investor psychology, market readiness, traction, commercialization, competition, business models, and storytelling. He explains how to define what your product replaces, what market shift is underway, why it is happening now, and why your company can lead it.

A key lesson is the difference between activity and repeatability. Real traction reveals patterns of demand: similar hospital adoption, rising utilization, recurring revenue, shorter sales cycles, stronger physician advocacy, or customers continuing after an initial study.

Learn how to make every slide lead naturally to the investor’s next question and connect each funding round to the evidence your company must create.

Disclaimer:

This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. The views expressed do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified professionals before making decisions.

Episode Breakdown:

00:00 How to Build an Investor Deck That Gets Attention
01:12 Intro + Why Investor Presentations Matter
02:47 What Founders Need to Know Before Pitching
05:01 Why Most Investor Decks Get the Strategy Wrong
07:28 How to Move Investors From Uncertainty to Conviction
09:18 Market Engineering and the Investor Story
11:05 Define the Market Before You Pitch the Product
13:25 Why Investors Need a Clear Category
15:30 Stop Selling Features and Start Selling Market Change
19:15 The Psychology of Attention and Memory
21:55 Why Now Is Critical to Your Investor Pitch
24:03 Product Market Fit vs Market Readiness
26:01 How to Explain Complex MedTech Simply
29:12 Show Investors Proof, Not Noise
31:04 What Real Traction Looks Like
32:23 How to Prove Repeatable Market Demand
35:01 What Your Funding Round Should Actually Prove
37:05 A Better Way to Present Market Opportunity
39:15 How to Position Against Competitors
41:16 Turning Adoption Into a Business Model
43:43 How Market Signals Show Growing Demand
45:12 Sell Investors the Future, Not Just the Product
47:10 How to Build a Stronger Team and Funding Story
48:18 How Every Investor Deck Should Flow
50:01 Final Investor Pitch Lessons
51:03 Outro

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit https://GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

In this episode, Omar Khateeb speaks with Amy Kruse, General Partner and Chief Investment Officer at Satori Neuro, about the intersection of neuroscience, neurotechnology, AI, brain health innovation, and venture capital.

A neuroscientist, DARPA leader, defense executive, entrepreneur and investor, Amy explains Satori Neuro's ecosystem approach. Interests include neuromodulation, precision psychiatry, biomarkers, digital therapeutics, psychedelics, the gut-brain axis, diagnostics and access to care.

The conversation explores systems-level neuroscience and targeted interventions such as TMS, tDCS and low-intensity focused ultrasound. Amy shares how imaging, biomarkers, personalized therapies, and neuromodulation could move psychiatry toward care designed around each patient.

Omar and Amy also discuss AI brain models, multimodal data, proprietary datasets, defensible platforms, brain-computer interfaces, closed-loop systems, sleep tech, consumer devices, cash-pay care, and pathways that could bring advanced treatments into homes and local clinics.

For founders and investors, Amy explains clinical milestones, seed and Series A expectations, tranche financing, investor pitches, market pull, and why excellent science needs a credible commercialization strategy.

DISCLAIMER
This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions.

EPISODE BREAKDOWN
00:00 Why Neurotechnology Is Entering a New Era
00:51 Intro + Meet Amy Kruse
02:57 From DARPA Neuroscience to Venture Capital
07:07 Satori Neuro's Investment Thesis
10:05 Market Engineering + MedTech Commercialization
13:09 Precision Psychiatry and Targeted Brain Therapies
16:29 AI and Foundation Models for the Brain
18:27 What Creates a Defensible AI Moat?
20:13 Why the US Needs to Invest in Neurotechnology
22:34 The Future of Brain-Computer Interfaces
25:14 Building the Next Neurotech Giant
29:21 Why Neurotech Needs Platform Companies
31:30 Brain-Computer Interfaces and Pharma
34:14 Why Reimbursement Isn't the Only Path
38:08 Bringing Neurotechnology Closer to Patients
41:01 What MedTech Founders Need to Know About Fundraising
44:10 What Makes an Early-Stage Startup Investable?
45:49 Why Great Science Alone Isn't Enough
47:14 The Biggest Founder Pitching Mistakes
49:38 A Better Way to Pitch Investors
53:05 The Wildest Investor Pitch Story
54:30 Neuroplasticity and Neuromodulation
57:49 Consumer Neurotech and Human Performance
01:00:10 Why Consumer Neurotech Hasn't Exploded Yet
01:01:23 The Billion-Dollar Opportunity in Sleep Tech
01:03:36 Why Neurotech Form Factor Matters
01:05:11 Rapid Fire + Amy's Favorite Health Tech
01:07:27 The Future of Precision Brain Medicine
01:08:58 Final Thoughts
01:09:30 Outro

Are you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.

SUBSCRIBE
YouTube: https://www.youtube.com/@thestateofmedtech
LinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

FOLLOW THE STATE OF MEDTECH
LinkedIn: https://www.linkedin.com/company/thestateofmedtech/
Instagram: https://www.instagram.com/stateofmedtech/
TikTok: https://www.tiktok.com/@stateofmedtechpod
X: https://x.com/stateofmedtech
Facebook: https://www.facebook.com/stateofmedtech

FOLLOW OMAR M. KHATEEB
LinkedIn: https://www.linkedin.com/in/okhateeb/
Instagram: https://www.instagram.com/omar.m.khateeb/
TikTok: https://www.tiktok.com/@omar.m.khateeb
X: https://x.com/OmarMKhateeb
Facebook: https://www.facebook.com/OmarMKhateeb

#neurotechnology #brainhealth #neuromodulation #medtech #healthcareinnovation

In this solo episode, Omar Khateeb examines Peter Thiel’s most overlooked lesson for MedTech founders: breakthrough technology does not create its own path to customers, investors, clinicians, or commercial adoption.

Drawing from the sales and distribution chapter of Zero to One, Omar explains why commercialization begins long before FDA clearance or product launch. A MedTech company is already selling when it recruits employees, raises capital, engages physician advisors, secures clinical partners, and asks hospitals to support a future that has not yet been fully proven.

The discussion explores why genuinely innovative technologies require sophisticated market education, how founders can reduce uncertainty across complex hospital buying decisions, and why technical differentiation must be supported by a credible narrative, economic case, adoption strategy, and distribution model. Omar also examines fundraising, category creation, investor confidence, physician advocacy, early adopters, recruiting, public relations, and market engineering.Ultimately, the episode argues that founders must build belief before they can build revenue.

The companies that understand this early create stronger organizations, attract better talent, earn greater investor confidence, and give meaningful healthcare innovation a credible path toward patients.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why Great MedTech Products Still Fail

01:04 Intro + Peter Thiel's Biggest Lesson

03:51 Why Every Founder Is Always Selling

06:05 Getting Comfortable With Rejection

06:58 The Most Overlooked Chapter in Zero to One

11:27 Why Market Engineering Matters

13:34 If You Build It, Will They Come?

15:12 Why Distribution Is Part of Product Design

18:05 Why New Categories Need Better Storytelling

21:10 The Biggest Sales Mistake MedTech Founders Make

24:30 Why Selling Is Really About Building Belief

27:10 Your Biggest Competitor Is Doing Nothing

31:24 Market Engineering Starts Before Launch

32:45 Why Founders Must Sell to Investors and Employees

34:47 The Hidden Power of PR and Reputation

38:05 The First Thing You Sell Is Belief

39:38 Final Lessons From Zero to One

41:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #startupstrategy #marketanalysis #gotomarket #peterthiel

Michael Minogue, 2026 Republican Endorsed Candidate for Governor of Massachusetts, President and CEO of Minogue Consulting, and former CEO of Abiomed, joins Omar Khateeb to share the leadership principles behind one of MedTech's most remarkable growth stories.

The conversation explores how Abiomed evolved from a struggling company into a $17 billion MedTech leader by creating an entirely new category around heart recovery rather than competing within an existing market. Michael explains how leadership, commercialization, physician adoption, innovation, culture, disciplined execution, and patient first thinking combined to establish a new global standard of care while delivering extraordinary clinical and business outcomes.

Together, they discuss category leadership, cardiovascular innovation, crisis management, organizational culture, regulatory strategy, data driven improvement, leadership under pressure, talent development, servant leadership, and why the greatest healthcare companies are built by leaders who remain obsessed with continuous improvement, long term value creation, and patient impact.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 How Abiomed Became a $17 Billion MedTech Success

01:23 Intro + Meet Former Abiomed CEO Mike Minogue

04:30 The Vision That Changed Abiomed Forever

08:41 Why Heart Recovery Beat Heart Replacement

12:20 Creating a New Standard of Care

14:39 Building the Heart Recovery Category

16:47 Engineering a Market, Not Just a Product

17:06 Learn, Adapt, Execute

21:54 How Data Improved Patient Survival

25:25 The Hardest Leadership Lesson

26:20 Ranger School and Building Mental Toughness

31:20 Surviving a Two Year Attack on the Company

34:05 Turning Crisis Into Competitive Advantage

37:52 Why Mike Chose Public Service

41:18 Running a State Like a Business

44:54 Leadership, Service, and the Future of Massachusetts

46:46 One Message for Every Entrepreneur

48:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#heartrecovery #medtech #medicaldevices #leadership #healthcareinnovation

In this episode, Omar Khateeb explores why commercialization is not a launch event but a long-term process of engineering market belief. Strong technology, FDA clearance, clinical validation, and venture funding reduce technical risk, yet they do not guarantee that physicians, investors, or strategic acquirers will change their behavior.

The discussion introduces the principles of Market Engineering, the Traction Gap, and Category Design, explaining how successful MedTech companies deliberately build credibility, investor confidence, physician advocacy, and repeatable adoption before expecting commercial scale. Omar also examines why category leaders capture the majority of economic value, why attention should never be confused with adoption, and why defining the market is often more valuable than competing inside someone else's category.

Whether you're a founder, executive, investor, or commercialization leader, this episode offers a strategic framework for creating stronger market positioning, accelerating clinical adoption, and building sustainable MedTech growth.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why Most MedTech Startups Fail After Raising Capital

01:03 Intro + Why Great Technology Still Struggles

02:35 When Commercialization Really Begins

04:28 The Biggest Risk Most Founders Ignore

06:48 Why Great Products Still Fail in the Market

08:52 Product Engineering vs Market Engineering

11:10 The Traction Gap Every Founder Must Understand

13:08 Why Raising Money Doesn't Prove Market Demand

15:00 Repeatable Traction vs One-Time Success

17:12 Attention Is Not Adoption

19:02 Why Category Leaders Capture Most of the Market

21:05 Build a Category Before You Build Demand

23:02 Why Category Design Determines Who Wins

24:37 Final Takeaways

25:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #startupstrategy #category #gotomarket #healthcareinnovation

The future of healthcare may be shaped less by incremental innovation and more by technologies that fundamentally change how we understand the human brain.In this episode, Omar Khateeb is joined by Brom Rector, Founder of XEIA Venture Partners, and Samantha Rector, General Partner of XEIA Venture Partners, for an in-depth conversation about neurotechnology, AI, longevity, venture capital, and the Human 3 vision for the future of medicine.They explore why neuroscience represents one of healthcare's largest unmet opportunities, how AI is accelerating biological discovery, why brain computer interfaces and neuromodulation are attracting serious investment, and how rigorous scientific thinking separates durable innovation from industry hype.The discussion also covers commercialization, preventative healthcare, lifestyle medicine, founder psychology, venture investing, and why tomorrow's healthcare leaders may build technologies that don't simply treat disease but elevate human health itself.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why We Still Know So Little About the Brain

01:27 Intro + Meet the XEIA Ventures Team

02:26 From Drug Discovery and Quant Finance to Venture Capital

05:08 Why They Left Traditional Careers to Build a Fund

08:06 Building a Public Investment Thesis Through Content

10:38 Why a Husband and Wife Built a Venture Fund Together

14:44 Family Businesses, Long-Term Thinking, and Generational Wealth

17:15 How XEIA Expanded Beyond Psychedelics

19:11 The Human Three Manifesto Explained

22:52 Investing Beyond Disease Toward Human Performance

28:08 Lifestyle Medicine and the Massive Opportunity in Healthcare

30:24 Will Consumers Choose Medical Devices Like They Choose Wearables?

44:44 The Most Exciting Investments in XEIA's Portfolio

47:05 The Untapped Opportunity in Sexual Health Innovation

50:05 Why Nontraditional Healthcare Markets Create Massive Companies

53:10 How XEIA Evaluates Founders and Breakthrough Technologies

01:01:32 The Biggest Mistakes Founders Make When Raising Capital

01:05:26 Where Neurotechnology and AI Are Headed Next

01:09:08 Why This Is the Best Time to Build in Healthcare

01:12:08 Final Advice for Founders and Investors

01:13:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#neurotechnology #brainhealth #mentalhealthinnovation #medtech #healthcareinnovation 

Click here to get the 2026 H1 HSBC Report https://www.marketcraft.ai/resources/hsbc-venture-healthcare-report-2026

In this episode, Omar Khateeb sits down with Henry Peck of LSI and Jon Norris, Managing Director of HSBC Innovation Banking, to analyze the H1 2026 Mid Year Healthcare Venture Trends Report and explain what today's healthcare investment landscape means for founders, investors, executives, and innovators building the future of MedTech.

The conversation goes beyond headline funding announcements to examine the deeper signals driving healthcare venture capital. Together, they discuss the record pace of healthcare investment, MedTech financing, AI adoption, diagnostics, neurotechnology, cardiovascular innovation, commercialization, IPO activity, strategic acquisitions, and the changing expectations investors now place on emerging healthcare companies. Henry also shares insights from LSI's proprietary market intelligence and Compass AI platform, explaining how healthcare venture trends, investor behavior, commercialization milestones, and financing dynamics may shape the industry's next phase of growth.

Whether you're raising capital, evaluating investment opportunities, or leading healthcare innovation, this episode provides valuable perspective on where healthcare venture is heading after H1 2026.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 - Introduction & HSBC Healthcare Report Overview

01:28 - Episode 400 Celebration & Guest Intro

05:19 - Key Industry Trends in H1 Venture Healthcare

13:02 - Market Engineering & Growth Strategies

16:02 - Cardiovascular Funding Paradox & Financing Bottlenecks

17:11 - John Norris on First-Financing Gaps & PMA Track Deals

20:37 - Structural Risks in MedTech Series B Funding

25:41 - Sector Spotlight: Neuro Growth vs. Cardiovascular Signals

33:29 - John Norris on Exit Windows & M&A Recovery

46:55 - John Norris on Evolving Investor Preferences & Milestone Expectations

55:56 - John Norris on Undervalued Opportunities: Imaging + AI

01:01:30 - Reimbursement Arcs & Clinical Adoption Challenges

01:05:45 - John Norris’s Bold 2026 M&A Predictions

01:12:27 - 2026 Market Outlook: Winner-Take-All Dynamics

01:18:35 - Final Takeaways & Wrap-Up

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #healthcareinnovation #medicaldevices #healthtech #venturecapital

Innovation rarely arrives through incremental improvements.

It emerges when industries become willing to fund thousands of parallel experiments around a shared vision of the future.

In this solo episode, Omar Khateeb explores why productive bubbles have repeatedly accelerated humanity's greatest technological breakthroughs and why MedTech may need its own period of ambitious experimentation to unlock the next generation of category defining companies.Drawing lessons from semiconductor history, Silicon Valley, structural heart, robotics, AI, and healthcare, Omar explains why bubbles should be measured by the infrastructure, knowledge, talent, and capabilities they leave behind rather than the valuations they temporarily create.The discussion also covers the J curve of innovation, category design, market engineering, venture capital, ecosystem building, and why the companies that redefine industries begin by changing beliefs before changing products.

This episode presents a strategic framework for founders, investors, and MedTech leaders looking to build markets that shape the future instead of simply improving the present.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

Episode Breakdown:

00:00 Why Bubbles Drive Innovation

01:06 Intro + Why MedTech Needs More Bubbles

03:50 Vision Before Innovation

05:09 Why Progress Slows Down

08:32 Why Innovation Comes in Waves

12:25 Why Markets Must Be Engineered

15:26 The J Curve of Breakthrough Innovation

19:20 Why Every Breakthrough Looks Irrational

22:08 The Hidden Value of Productive Bubbles

25:07 Parallel Experiments Build the Future

28:02 Why Ecosystems Beat Individual Companies

30:18 Failure Creates Future Winners

33:55 Why MedTech Needs More Experimentation

39:38 Optimization vs Reinvention

43:58 Purpose Drives Breakthrough Innovation

46:06 The Innovation Flywheel Explained

49:17 Final Takeaways

50:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#medtech #innovation #startupstrategy #futureofhealthcare #category

Building the Intelligence Platform for Modern Surgery.

The next breakthrough in surgery may not come from another robot. It may come from intelligence.

In this episode, Omar Khateeb speaks with Peter Verrillo, CEO of Redefine Surgery, about building the technology platform that brings computer vision, Physical AI, and world models into the operating room.Peter shares why Collaborative Surgical Intelligence creates a different path than autonomous surgery, how AI mentors can preserve the expertise of master surgeons, and why understanding movement, anatomy, and surgical judgment requires far more than large language models.The conversation also explores how enabling technologies create stronger long-term value than standalone products, why open surgery represents one of healthcare's largest untapped AI opportunities, and how partnering directly with medical device companies accelerates adoption across the industry.

This episode delivers strategic insight into where surgical innovation, artificial intelligence, and MedTech platform companies are heading next.

This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. 

Episode Breakdown:

00:00 Why AI Needs to Move Beyond Surgical Robots

00:52 Intro + Meet Peter Verrillo

03:29 Why Open Surgery Has Been Left Behind

07:04 Collaborative Surgical Intelligence Explained

10:14 Why Autonomous Surgery Isn't the Goal

12:01 Why Markets Must Be Engineered

15:10 The Opportunity in Open Orthopedic Surgery

17:05 What Makes Redefining Surgery Different?

20:19 Why Tech Talent Is Transforming MedTech

24:01 The Nvidia Business Model for Surgery

27:06 How Medical Device Companies Benefit

29:36 How Redefine Can Challenge Industry Leaders

31:38 Training AI With the World's Best Surgeons

34:49 Physical AI and World Models Explained

37:09 Revenue Before Commercialization

40:10 Why Traditional MedTech Is Falling Behind

44:02 The Economics of Surgical Robotics

46:11 The Long Term Vision for Redefine Surgery

49:26 Why AI Investors Are Looking at MedTech

50:00 Outro

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/@thestateofmedtech

Subscribe to our LinkedIn Newsletter

https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech/

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpod

X https://x.com/stateofmedtech

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech

Follow Omar M. Khateeb on

LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

TikTok https://www.tiktok.com/@omar.m.khateeb

X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateeb

Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb

#surgicalinnovation #medtech #healthcareinnovation #medicaldevices #artificialintelligence